MetaCap

Rallybio Quarterly Balance Sheet

NASDAQ: RLYBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.47-0.05 (-0.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Rallybio financial position

As of Sep 30, 2026, Rallybio reported total assets of $95.6 million, up 41.3% from a year earlier against total liabilities of $3.3 million. Shareholders' equity stood at $92.3 million, or 96.6% of assets. The company held $90.7 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 28.87, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Rallybio balance sheet (quarterly)

Rallybio quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Cash & Equivalents90.69M92.85M41.30M31.37M32.12M9.45M14.78M13.90M25.32M16.67M19.30M24.49M
Short-Term Investments005.50M23.36M27.20M36.30M39.72M51.61M49.82M71.94M74.87M85.44M
Total Current Assets94.77M97.25M53.49M61.25M66.63M50.27M57.38M67.84M78.23M91.44M98.55M114.79M
Property, Plant & Equipment0020.00K23.00K26.00K61.00K87.00K115.00K145.00K177.00K211.00K246.00K
Total Assets95.58M98.06M54.47M62.26M67.66M51.00M57.98M68.11M79.01M92.43M99.36M115.62M
Accounts Payable7.00K833.00K940.00K126.00K269.00K119.00K400.00K278.00K583.00K1.22M470.00K976.00K
Total Current Liabilities3.28M3.57M4.14M4.22M4.52M5.04M3.91M6.24M8.19M12.16M10.09M9.26M
Total Liabilities3.28M3.57M4.20M4.30M4.63M5.04M3.91M6.45M8.19M12.41M10.20M9.44M
Shareholders' Equity92.30M94.50M50.28M57.96M63.03M45.96M54.07M61.65M70.82M80.02M89.16M106.18M
Retained Earnings-269.34M-266.61M-310.28M-302.00M-296.15M-312.16M-302.46M-293.02M-281.98M-270.51M-254.27M-235.25M
Net Cash (Debt)90.69M92.85M46.80M54.74M59.32M45.75M54.49M65.51M75.14M88.61M94.17M109.93M
Shares Outstanding5.33M5.31M5.29M5.28M41.94M41.71M41.61M5.19M41.49M41.49M37.81M37.83M

This table shows 12 quarterly periods of Rallybio's balance sheet, from Q3 2026 back to Q4 2023, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow RLYB's reporting calendar. What is a balance sheet?

More financial data